Disseminated Intravascular Coagulation in Sepsis and Associated Factors

Ikhwan Rinaldi1,2, Mondastri Korib Sudaryo1, Nurhayati Adnan Prihartono1

  • 1Department of Epidemiology, Faculty of Public Health, Universitas Indonesia, Depok 16424, Indonesia.

Insights

Sepsis patients with low albumin, respiratory infections, or receiving antibiotics for at least one hour face a higher risk of developing disseminated intravascular coagulation (DIC). This study identified key risk factors for DIC in sepsis patients.

Area of Science:

  • Critical Care Medicine
  • Hematology
  • Infectious Diseases

Background:

  • Sepsis, a life-threatening organ dysfunction due to an excessive immune response to infection, is increasing globally and is a leading cause of ICU mortality.
  • Disseminated Intravascular Coagulation (DIC) is a serious coagulopathy associated with sepsis, characterized by thrombosis and increased bleeding risk.
  • The complex pathophysiology of DIC in sepsis necessitates further research into its mechanisms and risk factors.

Purpose of the Study:

  • To analyze the incidence and risk factors for Disseminated Intravascular Coagulation (DIC) in patients diagnosed with sepsis.
  • To identify independent predictors associated with the development of DIC among sepsis patients.

Main Methods:

  • A retrospective cohort study involving 248 sepsis patients (diagnosed via qSOFA score ≥2) admitted between January 2016 and October 2022.
  • Patients were monitored for DIC development or sepsis recovery; medical records were analyzed.
  • Bivariate and multivariate logistic regression analyses were employed to determine risk factors and their odds ratios (ORs).

Main Results:

  • The prevalence of DIC among sepsis patients was 20.2% (50 out of 248 patients).
  • Multivariate analysis revealed significant associations between DIC development and low albumin levels (≤2.5 g/dL; OR: 2.363), respiratory infections (OR: 2.414), and antibiotic treatment initiated ≥1 hour after diagnosis (OR: 2.181).
  • The Area Under the Curve (AUC) for the predictive model was 0.705.

Conclusions:

  • Low serum albumin, presence of respiratory infection, and delayed antibiotic treatment (≥1 hour) are identified as independent risk factors for DIC in sepsis patients.
  • The findings highlight the importance of monitoring these factors for early DIC detection and intervention in sepsis management.
  • A prevalence of 20.2% for DIC in sepsis patients underscores the clinical significance of this complication.

Related Concept Videos

Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
1.1K
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
8.8K
Coagulation01:09

Coagulation

The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
7.2K
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
838
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
26
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
18